Tenvir EM Tablet contains a fixed-dose combination of Tenofovir Disoproxil Fumarate (300 mg) and Emtricitabine (200 mg). It is widely prescribed for the treatment and prevention of HIV-1 infection, often used as part of antiretroviral therapy (ART) and in pre-exposure prophylaxis (PrEP). Trusted by healthcare providers worldwide, this medicine helps reduce viral load, improve immune function, and lower the risk of HIV transmission.

For more medical insights, you can explore resources on Mayo Clinic, Drugs.com, and the official FDA guidelines.

Key Benefits & Uses

• Helps control HIV infection and prevents progression to AIDS.

• Effective in reducing the viral load and boosting CD4 cell counts.

• Recommended for PrEP (Pre-Exposure Prophylaxis) to reduce the risk of acquiring HIV.

• Improves long-term health outcomes when used as part of a combination therapy.

• Backed by global research studies available on PubMed and WHO.

How to Use

• Take one Tenvir EM Tablet once daily, with or without food, as prescribed by your doctor.

• For PrEP use, consistency is essential—do not skip doses.

• Always follow your healthcare provider’s directions and check dosage adjustments if you have kidney issues.

• Learn more about correct administration and drug interactions from WebMD and Healthline.

Important Safety Information

• Not recommended in patients with severe kidney or liver problems unless advised by a physician.

• Regular monitoring of kidney function and bone health is important.

• Inform your doctor if you are pregnant, breastfeeding, or taking other medications.

• Do not stop treatment suddenly, as this may cause viral resistance.

Common Side Effects

• Nausea, diarrhea, or mild stomach upset

• Headache or dizziness

• Fatigue or weakness

• Rare: kidney problems, bone thinning (osteopenia/osteoporosis), or lactic acidosis

If side effects persist or worsen, consult your healthcare provider or visit trusted sources like Drugs.com and Mayo Clinic.

Why Choose Tenvir EM Tablet?

• Globally recommended as part of first-line HIV treatment and prevention.

• Proven safety and effectiveness supported by clinical studies.

• Recognized by FDA, WHO, and global health authorities.

• Convenient once-daily dose improves adherence and outcomes.